Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Polycystic Ovary Syndrome 18Carcinoma, Non-Small-Cell Lung 14Colorectal Neoplasms 11Lung Neoplasms 9Recurrence 7Neoplasm Metastasis 5Colonic Neoplasms 5Breast Neoplasms 5Rectal Neoplasms 4Ovarian Neoplasms 4Lymphoma, T-Cell, Peripheral 4Infertility 4Neoplasms 3Lymphoma, T-Cell 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Sezary Syndrome 2Papillomavirus Infections 2Mycosis Fungoides 2Meningeal Carcinomatosis 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, B-Cell 2Lymphoma 2Insulin Resistance 2Infertility, Female 2Hyperandrogenism 2Head and Neck Neoplasms 2Diabetes, Gestational 2Carcinoma, Transitional Cell 2Atypical Squamous Cells of the Cervix 2

Interventions

Carboplatin 159Paclitaxel 153Bevacizumab 85Taxes 48Gemcitabine 48liposomal doxorubicin 47Topotecan 41Cisplatin 35pembrolizumab 33Cyclophosphamide 27olaparib 25Immunoglobulin G 24Disulfides 24Specimen Handling 21Drug Therapy 20Docetaxel 20niraparib 18Magnetic Resonance Spectroscopy 18Doxorubicin 17Biopsy 15mirvetuximab soravtansine 14Hyperthermic Intraperitoneal Chemotherapy 14rucaparib 13Nivolumab 12Cytoreduction Surgical Procedures 11Chemotherapy, Adjuvant 10Albumin-Bound Paclitaxel 10veliparib 9Platinum 9Neoadjuvant Therapy 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fallopian Tube Neoplasms × Folic Acid × Clear all
NCT01188876 2018-01-19

Carboplatin/Pralatrexate in Recurrent Platinum-Sensitive Ovarian, Fallopian or Primary Peritoneal Cancer

Massachusetts General Hospital

Phase 1/2 Completed
50 enrolled 15 charts
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡